AR and prostate cancer: Therefore, the basic physiological level of wild-type p53 is necessary for AR signal and has a protective effect on it, but the balance between p53 and AR is eliminated as cancer progresses (94), and deletion of p53 leads to androgen-induced transactivation of NKX3.1, which promotes prostate cancer progression.